WHWK financials
Whitehawk Therapeutics (WHWK) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- WHWK revenue was $7.14M in fiscal 2025, net income -$20.60M.
WHWK income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $7.14M | $6.38M | -$114.40M | -$20.60M | -0.33 |
| 2024 | $25.98M | $22.96M | -$67.46M | -$63.69M | -2.36 |
| 2023 | $24.35M | $21.55M | -$71.93M | -$65.77M | -2.44 |
| 2022 | $15.22M | $13.88M | -$62.68M | -$60.51M | -2.69 |
| 2021 | $14.00M | $14.00M | -$111.22M | -$110.74M | -12.41 |
| 2020 | $14.00M | – | -$2.55M | -$3.48M | -1.76 |